Princeton, NJ – November 16, 2021 – Guerbet LLC, the US affiliate of Guerbet, a global leader in medical imaging, was awarded a contract with healthcare performance improvement company, Vizient, Inc. This contract provides Vizient members nationwide access to Guerbet’s Hydra VisionTM Digital Imaging System with negotiated pricing, terms and conditions and additional support.
“We are pleased to have received this contract award and to begin working with Vizient members and building those relationships,” said Tom McLaughlin, Vice President, North America at Guerbet. “Our dedication to putting people and patient experience first is a driving force behind this decision to seek out this agreement with Vizient. Expanding access to our products through the Vizient membership, and offering greater training and support, provides greater opportunities for patient care.”
The Hydra VisionTM Digital Imaging System is an X-ray system and flat imaging table, rated to 750-pounds, that facilitates digital, radiologic and/or fluoroscopic procedures requiring a beam of diagnostic-quality radiation. The system is designed to assist in the diagnosis, planning and treatment of urological disorders, while streamlining workflows and improving efficiency. The moving imaging system allows the patient to remain stationary during sensitive procedures and provides secure, real-time digital X-ray imaging. Though engineered for urological imaging, it can also be used for in gastroenterological, gynecological, orthopedic, respiratory, and cardiovascular cases.
The contract enables Vizient members to purchase Guerbet’s Hydra VisionTM Digital Imaging System and associated consumable supplies at negotiated prices. For Vizient members, the contracted rates also include relevant training plus warranty parts and service.
Vizient is the largest member-driven healthcare performance improvement company in the country— representing an annual purchasing volume of more than $110 billion. Their diverse membership and customer base includes academic medical centers, pediatric facilities, community hospitals, integrated health delivery networks and nonacute health care providers.
The Hydra VisionTM System is recognized for its image quality and ease of use.
To learn more about Guerbet and its suite of products, visit www.guerbet.com.
At Guerbet, we build lasting relationships so that we enable people to live better. This is our purpose. We are a leader in medical imaging worldwide, offering a wide range of pharmaceutical products, medical devices, digital and AI solutions for diagnostic and interventional imaging. A pioneer since 95 years in the field of contrast media with over 2,600 people globally, we are continuously innovating with 10% of revenue dedicated to Research & Development and four centers in France, Israel and the United States. Guerbet (GBT) is listed on Euronext Paris (segment B – mid caps) and generated €712 million in revenue in 2020. For more information, please visit www.guerbet.com